back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-04-26 09:02 Tx date 2019-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
2,366 | |
| Filed 2019-04-26 08:55 Tx date 2019-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,021 vol |
29,021 | |
| Filed 2019-04-18 10:31 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,077.48
-738 vol $1.46 each |
94,922 | |
| Filed 2019-04-18 10:31 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,077.48
-738 vol $1.46 each |
94,922 | |
| Filed 2019-04-18 10:27 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
95,660 | |
| Filed 2019-04-18 10:27 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
95,660 | |
| Filed 2019-04-18 10:24 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-18 10:24 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-18 10:13 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,946
+4,538 vol $1.09 each |
99,460 | |
| Filed 2019-04-18 10:13 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,946
+4,538 vol $1.09 each |
99,460 | |
| Filed 2019-03-20 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,040
+3,231 vol $1.56 each |
94,160 | |
| Filed 2019-02-20 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,053
+3,139 vol $1.61 each |
90,929 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,012
+3,038 vol $1.65 each |
87,790 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,392
+3,571 vol $1.51 each |
84,752 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,398
+3,575 vol $1.51 each |
81,181 | |
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,398
+2,117 vol $2.55 each |
77,606 | |
| Filed 2018-09-20 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,395
+1,934 vol $2.79 each |
75,489 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,394
+2,083 vol $2.59 each |
73,555 | |
| Filed 2018-07-20 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,416
+2,276 vol $2.38 each |
71,472 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,128
+2,220 vol $2.31 each |
69,196 | |
| Filed 2018-05-18 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,754
+1,601 vol $2.97 each |
66,976 | |
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,029
+1,405 vol $3.58 each |
65,375 | |
| Filed 2018-04-08 Tx date 2018-04-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2018-04-08 Tx date 2018-04-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
63,970 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
27,000 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,029
+1,488 vol $3.38 each |
62,470 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,023
+1,469 vol $3.42 each |
60,982 | |
| Filed 2018-01-19 Tx date 2018-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,995
+1,350 vol $3.70 each |
59,513 | |
| Filed 2017-12-20 Tx date 2017-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,373
+1,357 vol $3.96 each |
58,163 | |
| Filed 2017-11-19 Tx date 2017-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,376
+1,393 vol $3.86 each |
56,806 | |
| Filed 2017-10-19 Tx date 2017-10-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,383
+1,428 vol $3.77 each |
55,413 | |
| Filed 2017-09-19 Tx date 2017-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,242
+1,304 vol $4.02 each |
53,985 | |
| Filed 2017-08-20 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,013
+1,097 vol $4.57 each |
52,681 | |
| Filed 2017-07-22 Tx date 2017-07-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,876
+1,060 vol $4.60 each |
51,584 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,382
+1,355 vol $4.71 each |
50,524 | |
| Filed 2017-06-07 Tx date 2017-06-06 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,910
+1,400 vol $5.65 each |
49,169 | |
| Filed 2017-06-05 Tx date 2017-06-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$105,090
+18,600 vol $5.65 each |
47,769 | |
| Filed 2017-05-24 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2017-05-18 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,710
+3,500 vol $5.06 each |
23,500 | |
| Filed 2017-05-17 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,098
+714 vol $4.34 each |
29,169 | |
| Filed 2017-04-19 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,100
+838 vol $3.70 each |
28,455 | |
| Filed 2017-04-05 Tx date 2017-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
27,617 | |
| Filed 2017-04-05 Tx date 2017-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-03-18 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,100
+829 vol $3.74 each |
26,117 | |
| Filed 2017-02-20 Tx date 2017-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,096
+776 vol $3.99 each |
25,288 | |
| Filed 2017-01-18 Tx date 2017-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,098
+767 vol $4.04 each |
24,512 | |
| Filed 2016-12-19 Tx date 2016-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,091
+896 vol $3.45 each |
23,745 | |
| Filed 2016-11-18 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,100
+951 vol $3.26 each |
22,849 | |
| Filed 2016-10-22 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,964
+716 vol $4.14 each |
21,898 | |
| Filed 2016-10-22 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,965
+609 vol $4.87 each |
||
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,165
+1,182 vol $4.37 each |
21,182 | |
| Filed 2016-08-16 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2016-08-16 Tx date 2016-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$115,500
+20,000 vol $5.78 each |
20,000 | |
| Filed 2016-08-16 Tx date 2016-08-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-16 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,800
+20,000 vol $6.19 each |
20,000 | |
| Filed 2016-08-16 Tx date 2016-08-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-11 Tx date 2016-08-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|